🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Tablet(s) Serving Size
60 Servings
Other Combinations Product Type
60% Evidence Coverage

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
400 IU (100% DV)
✅ Within RDA (0.7× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.01mg UL 0.1mg
Calcium
1 Gram(s) (100% DV)
240 mg (24% DV)
✅ Within RDA (0.3× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 240mg UL 4000mg
400 mg (100% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 400mg

Other Ingredients

Modified Cellulose Cellulose modified Cellulose Gum Stearic Acid Titanium Dioxide color Magnesium Stearate Soy Lecithin Vegetable Glycerin Carnauba wax

Label Claims — Verification

All Other
Approved Health
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

The National Institutes of Health recommend that adults take 1,000 to 1,200 mg daily to reduce further bone loss and prevent osteoporosis-related fractures. Daily intakes above 2,000 mg are not likely to provide any additional benefit to bone health.

Recommendations: Take 3 tablets daily with food or as recommended by your healthcare professional.

⚠️ Warnings & Precautions

If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use.

🧪 Formulation Notes

Contains no sugar, salt, yeast, wheat, gluten, dairy products, artificial flavoring, or preservatives.

Additional Information

Adequate calcium as part of a healthful diet, along with physical activity, may reduce the risk of osteoporosis, a condition which affects middle-aged and older persons.

All colors used are from natural sources.

LZ77810.C01

Bone support combination

Product Details

UPC / SKU 8 71791 00387 3
DSLD Entry Date 2017-09-21
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 77803
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →